These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 11481624
21. Prevalence and profile of mutations associated with lamivudine therapy in Indian patients with chronic hepatitis B in the surface and polymerase genes of hepatitis B virus. Wakil SM, Kazim SN, Khan LA, Raisuddin S, Parvez MK, Guptan RC, Thakur V, Hasnain SE, Sarin SK. J Med Virol; 2002 Nov; 68(3):311-8. PubMed ID: 12226816 [Abstract] [Full Text] [Related]
22. Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases. Raimondo G, Costantino L, Caccamo G, Pollicino T, Squadrito G, Cacciola I, Brancatelli S. J Hepatol; 2004 Mar; 40(3):515-9. PubMed ID: 15123368 [Abstract] [Full Text] [Related]
23. A double-spliced defective hepatitis B virus genome derived from hepatocellular carcinoma tissue enhanced replication of full-length virus. Ma ZM, Lin X, Wang YX, Tian XC, Xie YH, Wen YM. J Med Virol; 2009 Feb; 81(2):230-7. PubMed ID: 19107969 [Abstract] [Full Text] [Related]
24. Dynamic changes of hepatitis B virus polymerase gene including YMDD motif in lamivudine-treated patients with chronic hepatitis B. Feng B, Wei L, Chen M, Wang L. Microbiol Res; 2008 Feb; 163(4):487-92. PubMed ID: 17317127 [Abstract] [Full Text] [Related]
25. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Hsieh YH, Su IJ, Wang HC, Chang WW, Lei HY, Lai MD, Chang WT, Huang W. Carcinogenesis; 2004 Oct; 25(10):2023-32. PubMed ID: 15180947 [Abstract] [Full Text] [Related]
29. Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients. Pollicino T, Isgrò G, Di Stefano R, Ferraro D, Maimone S, Brancatelli S, Squadrito G, Di Marco V, Craxì A, Raimondo G. Antivir Ther; 2009 Oct; 14(5):649-54. PubMed ID: 19704167 [Abstract] [Full Text] [Related]
30. Precore/core promoter mutations and genotypes of hepatitis B virus in chronic hepatitis B patients with fulminant or subfulminant hepatitis. Liu CJ, Kao JH, Lai MY, Chen PJ, Chen DS. J Med Virol; 2004 Apr; 72(4):545-50. PubMed ID: 14981756 [Abstract] [Full Text] [Related]
31. Hypermodification and immune escape of an internally deleted middle-envelope (M) protein of frequent and predominant hepatitis B virus variants. Tai PC, Suk FM, Gerlich WH, Neurath AR, Shih C. Virology; 2002 Jan 05; 292(1):44-58. PubMed ID: 11878907 [Abstract] [Full Text] [Related]
32. Infections by hepatitis B surface antigen gene mutants in Europe and North America. Tabor E. J Med Virol; 2006 Jan 05; 78 Suppl 1():S43-7. PubMed ID: 16622882 [Abstract] [Full Text] [Related]
34. Two distinct types of hepatitis B virus core promoter variants in Yemeni blood donors. Sallam TA, Tong CY. J Med Virol; 2002 Nov 05; 68(3):328-34. PubMed ID: 12226818 [Abstract] [Full Text] [Related]
38. Hepatitis B virus S gene mutants in a patient with chronic active hepatitis with circulating Anti-HBs antibodies. Mathet VL, Feld M, Espínola L, Sánchez DO, Ruiz V, Mandó O, Carballal G, Quarleri JF, D'Mello F, Howard CR, Oubiña JR. J Med Virol; 2003 Jan 05; 69(1):18-26. PubMed ID: 12436473 [Abstract] [Full Text] [Related]
40. Mutations within the hepatitis B virus genome among chronic hepatitis B patients with hepatocellular carcinoma. Bläckberg J, Kidd-Ljunggren K. J Med Virol; 2003 Sep 05; 71(1):18-23. PubMed ID: 12858404 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]